Payments to Acquire Property, Plant, and Equipment of Kymera Therapeutics, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Kymera Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Kymera Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $467,000, a 94% decline year-over-year.
  • Kymera Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $1,449,000, a 89% decline from 2024.
  • Kymera Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $12,838,000, a 63% decline from 2023.
  • Kymera Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $34,480,000, a 1116% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Kymera Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,449,000 -$11,389,000 -89% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $12,838,000 -$21,642,000 -63% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $34,480,000 +$31,644,000 +1116% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $2,836,000 +$1,239,000 +78% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $1,597,000 -$7,499,000 -82% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
2020 $9,096,000 +$8,564,000 +1610% 01 Jan 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
2019 $532,000 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY

Kymera Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $467,000 -$6,935,000 -94% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q1 2024 $7,402,000 +$3,393,000 +85% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q1 2023 $4,009,000 +$3,527,000 +732% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q1 2022 $482,000 +$318,000 +194% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $164,000 -$1,231,000 -88% 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022 2022 Q1
Q1 2020 $1,395,000 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.